Section B - Supplies or Services and PricesFunding Agreement • November 25th, 2021
Contract Type FiledNovember 25th, 2021This agreement provides funding for the research effort described in the recipient, Plasma Technologies LLC’s proposal entitled “Novel High Yield Anti-Covid-19 Immune Globulin Hyperimmune Manufacturing Process”, dated 29 July 2020, received in response to MCS BAA 17-01, which is hereby incorporated in its entirety by reference to include revisions dated 4 August 2018.